| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |